As a traditional thrombolytic
drug that has been marketed in China for many areas, Urokinase is widely used to treat acute myocardial infarction, cerebral thrombosis, pulmonary vein thrombosis, lower extremity vein thrombosis and other forms of vascular thrombosis.
The high NIHSS and MRS scores and low Barthel index score indicate poor recovery effect after thrombolytic
therapy leads to early normalization of both hemodynamic parameters and RV function, thus reducing mortality.
The aim of the present study was to compare the efficacies of thrombolytic
and standard anticoagulation therapy modalities on mortality and also to determine the safety of thrombolytic
therapy in subjects with submassive PE.
use in massive PE is warranted, but patients with sub-massive PE require case-by-case analysis with shared decision making.
Group III (SK) constituted of patients who received thrombolytic
therapy (streptokinase) were 111.
The use rate of tPA (Boehringer Ingelheim, GmbH) intravenous thrombolytic
therapy and the treatment situations of AIS patients with previous histories of cerebral hemorrhage within 4.5 h of arrival at the hospital were obtained.
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic
. Trends Neurosci 2009;32:48-55.
agents can minimize clot burden by clot lysis and can decrease the risk of recurrent Pes, and therefore long term pulmonary hypertension .
The third control renal angiography revealed complete lysis of the thrombus with no residue following the third dose of thrombolytic
Mean tricuspid annular peak systolic velocity (Sa) was 11.4 [+ or -] 2.3 cm/s in patients who were given thrombolytic
therapy compared to 11.2 [+ or -] 2.2 cm/s in whom thrombolytics
were not given.
Ischemic stroke is a predominant stroke type caused by cerebral blood supply interruption, rapidly resulting in energy depletion and cell death. Thrombolysis is a therapeutic approach to restore the blood supply in ischemic area based on the concept of penumbra, which is currently the most promising treatment for acute ischemic stroke (AIS). Clinical trials have demonstrated that intravenous (IV) and intra-arterial thrombolytic
therapies improve outcome when administered to select patients with AIS., What concern clinicians the most are complications after thrombolysis and whether revascularization can be achieved.